Nature's Way

Primadophilus Optima Advanced 60 Billion

F
N+ Score59
ProbioticsServing: 1 Capsule(s)Type: Other Combinations

Primadophilus Optima Advanced 60 Billion is a probiotic supplement from Nature's Way, designed to support gut health. This product contains a proprietary probiotic blend at 504mg, alongside NutraFlora scFOS at 75mg, a prebiotic fiber. With an N+ Score of 59 and a grade of 'F', its overall quality assessment is below average. The formula lists a total of 3 ingredients and maintains 100% label transparency, but specific dosages for individual probiotic strains are not disclosed, making it difficult to assess their efficacy. Research suggests that adequate and specific probiotic strains are crucial for targeted benefits, and the lack of detail here is a notable weakness. This product may be considered by individuals seeking a general probiotic blend with a prebiotic component, but without specific strain information or clinically dosed ingredients.

About This Product

Primadophilus Optima Advanced 60 Billion by Nature's Way is a probiotics supplement containing 3 active ingredients. It has earned an N+ Score of 59/100 (Grade F).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness33/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity65/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (3 ingredients)

IngredientAmountDose Adequacy
Total Carbohydrates1.000 Gram(s)N/A
NutraFlora scFOS75.000 mgN/A
Primadophilus Optima-60 Proprietary Probiotic blend504.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.